Skip to main content
Top
Published in: Acta Diabetologica 9/2018

01-09-2018 | Original Article

Association of branched chain amino acids related variant rs1440581 with risk of incident diabetes and longitudinal changes in insulin resistance in Chinese

Authors: Liping Xuan, Yanan Hou, Tiange Wang, Mian Li, Zhiyun Zhao, Jieli Lu, Yu Xu, Yuhong Chen, Lu Qi, Weiqing Wang, Yufang Bi, Min Xu

Published in: Acta Diabetologica | Issue 9/2018

Login to get access

Abstract

Aims

Previous genome-wide association studies reported rs1440581 was significantly associated with circulating branched chain amino acids (BCAAs) levels in Europeans. We aimed to investigate association of BCAAs related variant rs1440581 with incident T2D risk and longitudinal changes in glucose-related metabolic traits in a community-based prospective cohort of Chinese.

Methods

6043 non-diabetic participants aged ≥ 40 years from a community-based population at baseline were included and followed-up for 5 years. The BCAAs related variant rs1440581 was genotyped. Incident T2D was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L or taking anti-diabetic therapy. Anthropometry and biochemical measurements were evaluated at both baseline and follow-up.

Results

576 (9.5%) participants developed T2D during the 5-year follow-up. Each C-allele was associated with a 20% higher risk of incident T2D (odds ratio = 1.20, 95% confidence interval [1.05, 1.36]) after adjustments for the confounders. We did not find a main effect of the variant on increase in fasting serum insulin (FSI) level or insulin resistance (IR). However, we found rs1440581 significantly modified effect of weight gain on increase in FSI and HOMA-IR. In the C-allele carriers, body mass index increase was associated with greater increase in Log10_FSI (β ± SE 0.027 ± 0.002) and Log10_HOMA-IR (0.030 ± 0.003), as compared to T-allele (both P for interaction = 0.003).

Conclusions

BCAAs related genetic variant rs1440581 was associated with an increased risk of incident T2D in a Chinese population. This variant might modify effect of weight gain on development in IR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326CrossRefPubMedPubMedCentral Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326CrossRefPubMedPubMedCentral
2.
go back to reference Stancakova A, Civelek M, Saleem NK et al (2012) Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 61:1895–1902CrossRefPubMedPubMedCentral Stancakova A, Civelek M, Saleem NK et al (2012) Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 61:1895–1902CrossRefPubMedPubMedCentral
3.
go back to reference Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PloS One 5:e13953CrossRefPubMedPubMedCentral Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PloS One 5:e13953CrossRefPubMedPubMedCentral
4.
go back to reference Kettunen J, Tukiainen T, Sarin AP et al (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44:269–276CrossRefPubMedPubMedCentral Kettunen J, Tukiainen T, Sarin AP et al (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44:269–276CrossRefPubMedPubMedCentral
5.
go back to reference Lotta LA, Scott RA, Sharp SJ et al (2016) Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a mendelian randomisation analysis. PLoS Med 13:e1002179CrossRefPubMedPubMedCentral Lotta LA, Scott RA, Sharp SJ et al (2016) Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a mendelian randomisation analysis. PLoS Med 13:e1002179CrossRefPubMedPubMedCentral
6.
go back to reference Xu M, Qi Q, Liang J et al (2013) Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 127:1283–1289CrossRefPubMed Xu M, Qi Q, Liang J et al (2013) Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 127:1283–1289CrossRefPubMed
7.
go back to reference Goni L, Qi L, Cuervo M et al (2017) Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines (NUGENOB) randomized trial. Am J Clin Nutr 106(3):902–908PubMed Goni L, Qi L, Cuervo M et al (2017) Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines (NUGENOB) randomized trial. Am J Clin Nutr 106(3):902–908PubMed
8.
go back to reference Bi Y, Wang W, Xu M et al (2016) Diabetes genetic risk score modifies effect of bisphenol A exposure on deterioration in glucose metabolism. J Clin Endocrinol Metab 101:143–150CrossRefPubMed Bi Y, Wang W, Xu M et al (2016) Diabetes genetic risk score modifies effect of bisphenol A exposure on deterioration in glucose metabolism. J Clin Endocrinol Metab 101:143–150CrossRefPubMed
9.
go back to reference Xu M, Lv X, Xie L et al (2016) Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis. Diabetologia 59:307–315CrossRefPubMed Xu M, Lv X, Xie L et al (2016) Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis. Diabetologia 59:307–315CrossRefPubMed
10.
go back to reference Xu M, Huang Y, Xie L et al (2016) Diabetes and risk of arterial stiffness: a mendelian randomization analysis. Diabetes 65:1731–1740CrossRefPubMed Xu M, Huang Y, Xie L et al (2016) Diabetes and risk of arterial stiffness: a mendelian randomization analysis. Diabetes 65:1731–1740CrossRefPubMed
11.
go back to reference Tillin T, Hughes AD, Wang Q et al (2015) Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study. Diabetologia 58:968–979CrossRefPubMedPubMedCentral Tillin T, Hughes AD, Wang Q et al (2015) Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study. Diabetologia 58:968–979CrossRefPubMedPubMedCentral
13.
go back to reference Palmer ND, Stevens RD, Antinozzi PA et al (2015) Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 100:E463–E468CrossRefPubMed Palmer ND, Stevens RD, Antinozzi PA et al (2015) Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 100:E463–E468CrossRefPubMed
14.
go back to reference Guasch-Ferre M, Hruby A, Toledo E et al (2016) Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39:833–846CrossRefPubMedPubMedCentral Guasch-Ferre M, Hruby A, Toledo E et al (2016) Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39:833–846CrossRefPubMedPubMedCentral
15.
go back to reference Davey Smith G, Ebrahim S (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (Clin Res Ed) 330:1076–1079CrossRef Davey Smith G, Ebrahim S (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (Clin Res Ed) 330:1076–1079CrossRef
16.
go back to reference Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309–330CrossRefPubMed Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309–330CrossRefPubMed
18.
go back to reference Taneera J, Lang S, Sharma A et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122–134CrossRefPubMed Taneera J, Lang S, Sharma A et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122–134CrossRefPubMed
19.
go back to reference Lu G, Sun H, She P et al (2009) Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Investig 119:1678–1687CrossRefPubMed Lu G, Sun H, She P et al (2009) Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Investig 119:1678–1687CrossRefPubMed
20.
21.
go back to reference Lian K, Du C, Liu Y et al (2015) Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice. Diabetes 64:49–59CrossRefPubMed Lian K, Du C, Liu Y et al (2015) Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice. Diabetes 64:49–59CrossRefPubMed
22.
go back to reference Menni C, Fauman E, Erte I et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62:4270–4276CrossRefPubMedPubMedCentral Menni C, Fauman E, Erte I et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62:4270–4276CrossRefPubMedPubMedCentral
23.
go back to reference Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Swerdlow DI, Holmes MV et al (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379(9822):1214–1224CrossRef Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Swerdlow DI, Holmes MV et al (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379(9822):1214–1224CrossRef
Metadata
Title
Association of branched chain amino acids related variant rs1440581 with risk of incident diabetes and longitudinal changes in insulin resistance in Chinese
Authors
Liping Xuan
Yanan Hou
Tiange Wang
Mian Li
Zhiyun Zhao
Jieli Lu
Yu Xu
Yuhong Chen
Lu Qi
Weiqing Wang
Yufang Bi
Min Xu
Publication date
01-09-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1165-4

Other articles of this Issue 9/2018

Acta Diabetologica 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.